<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000488410"><TermName>CHIR-265</TermName><TermDefinition><DefinitionText>A substance being studied in the treatment of melanoma. CHIR-265 may block the growth of tumors and the growth of blood vessels from surrounding tissue to the tumor. It is a type of Raf kinase inhibitor and angiogenesis inhibitor.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>CHIR-265</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del melanoma. CHIR-265 podría impedir el crecimiento de los tumores y el crecimiento de los vasos sanguíneos del tejido que rodea el tumor. Es un tipo de inhibidor de la cinasa Raf y de la angiogénesis.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-12-01</DateFirstPublished></GlossaryTerm>
